aminoglutethimide has been researched along with Atrophy in 2 studies
Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malendowicz, LK | 2 |
2 other studies available for aminoglutethimide and Atrophy
| Article | Year |
|---|---|
Comparative studies on the effects of aminoglutethimide, metopirone, ACTH and hydrocortisone on the adrenal cortex of adult male rats. II. Histological and histochemical studies.
Topics: Acid Phosphatase; Adenosine Triphosphatases; Adrenal Glands; Adrenocorticotropic Hormone; Alkaline P | 1973 |
Steatotic degeneration of rat adrenocortical cells after treatment with aminoglutethimide.
Topics: Acid Phosphatase; Adrenal Gland Diseases; Alkaline Phosphatase; Aminoglutethimide; Animals; Atrophy; | 1972 |